Elizabeth A. Barrett - 31 Jan 2022 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Chief Executive Officer
Signature
/s/ Jason Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
31 Jan 2022
Net transactions value
-$62,118
Form type
4
Filing time
02 Feb 2022, 15:32:42 UTC
Previous filing
07 Jan 2022
Next filing
17 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise +5,000 +1.7% 303,220 31 Jan 2022 Direct F1
transaction URGN Ordinary Shares Sale $16,941 -2,235 -0.74% $7.58 300,985 31 Jan 2022 Direct F2
transaction URGN Ordinary Shares Options Exercise +13,333 +4.4% 314,318 31 Jan 2022 Direct F1
transaction URGN Ordinary Shares Sale $45,177 -5,960 -1.9% $7.58 308,358 31 Jan 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Restricted Stock Units Options Exercise $0 -5,000 -50% $0.000000 5,000 31 Jan 2022 Ordinary Shares 5,000 Direct F1, F3
transaction URGN Restricted Stock Units Options Exercise $0 -13,333 -33% $0.000000 26,667 31 Jan 2022 Ordinary Shares 13,333 Direct F1, F4
transaction URGN Stock Option (right to buy) Award $0 +150,000 $0.000000 150,000 31 Jan 2022 Ordinary Shares 150,000 $7.72 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer
F2 Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units
F3 The reporting person was granted restricted stock units ("RSUs") on January 31, 2020 representing 15,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2021.
F4 The reporting person was granted restricted stock units ("RSUs") on January 31, 2021 representing 40,000 ordinary shares. The RSUs vest in three equal annual installments from January 31, 2022.
F5 1/3 of the shares underlying the stock options will vest on each of January 31, 2023, January 31, 2024 and January 31, 2025